Bibliography
- Alberti A , BenvegnuL: Management of hepatitisC. J. Hepatol.38 , S104–S118 (2003).
- Hu KQ , VierlingJM, RedekerAG: Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.J. Viral Hepat.8(1) , 1–18 (2001).
- Fried , MW, Peter J, Hoots K et al.: Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon α-2b and ribavirin. Hepatology36 , 967–972 (2002).
- Lai MY , KaoJH, YangPM et al.: Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C.Gastroenterology111 , 1307–1312 (1996).
- Lauer GM , WalkerBD: Hepatitis C virus infection.N. Engl. J. Med.345 , 41–52 (2001).
- Manns MP , McHutchisonJG., Gordon SC et al.: Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet358 , 958–965 (2001).
- Fried MW , ShiffmanML, ReddyKR et al.: Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection.N. Engl. J. Med.347 , 975–982 (2002).
- Ferenci P : Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.J. Antimicrob. Chemother.53 , 15–18 (2004).
- Collier J , ChapmanR: Combination therapy with interferon-α and ribavirin for hepatitis C: practical treatment issues.BioDrugs15(4) , 225–238 (2001).
- Martinot-Peignoux M , MarcellinP, Pouteau MP et al.: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon α therapy in chronic hepatitis C. Hepatology22 , 1050–1056 (1995).
- Fried MW , HoofnagleJH: Therapy of hepatitis C.Semin. Liver Dis.15 , 82–91 (1995).
- Yee LJ , TangJ, GibsonAW, KimberlyR, Van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology33(3) , 708–712 (2001).
- Hijikata M , OhtaY, MishiroS: Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon.Intervirology43(2) , 124–127 (2000).
- Sugimoto Y , KuzushitaN, TakeharaT et al.: A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C. J. Viral Hepat.9(5) , 377–384 (2002).
- Kung SY , HwangJN: Neural networks for intelligent multimedia processing.Proceedings of the IEEE86 , 1244–1272 (1998).
- Erb RJ : Introduction to backpropagation neural network computation.Pharm. Res.10 , 165–170 (1993).
- Veng-Pedersen P , ModiNB: Application of neural networks to pharmacodynamics.J. Pharm. Sci.82 , 918–926 (1993).
- Brier ME , AronoffGR: Application of artificial neural networks to clinical pharmacology.Int. J. Clin. Pharm. Ther.34 , 510–514 (1996).
- Gobburu J , ChenEP: Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis.J. Pharm. Sci.85 , 505–510 (1996).
- Serretti A , SmeraldE: Neural network analysis in pharmacogenetics of mood disorders.BMC Med. Genet.5 , 27 (2004).
- Rumelhart DE , HintonGE, WilliamRJ: Learning internal representation by error propagation. Parallel Distributed Processing: Explorations. In:The Micro-Structure of Cognition, Volume 1, Foundations. MIT Press, Cambridge, MA, USA (1996).
- Neural Network Toolbox for use with MATLAB. The Mathworks Inc., Natick MA, USA (1998).
- Nestorov I , HadjitodorovST, PetrovI, RowlandM: Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.AAPS PharmSci.1(4) , 17 (1999).
- Hastie T , TibshiraniR, FriedmanJH: The Elements of Statistical Learning. Springer-Verlag, New York, USA (2001).
- Bishop CM : Neural networks for pattern recognition. Clarendon Press, Oxford, UK (1995).
- Hwang Y , LinE, LiaoY et al.: The benefits of pharmacogenomics for hepatitis therapy. Presented at: HVIII HUGO International Symposium on Mutation Detection in the Genome. Santorini, Greece, May 31–June 4 (2005).
- Jensen DM , MorganTR, MarcellinP et al.: Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy. Hepatology43(5) , 954–960 (2006).
- Maiellaro PA , CozzolongoR, MarinoP: Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C.Curr. Pharm. Des.10(17) , 2101–2109 (2004).
- White H : Connectionist nonparametric regression: multilayer feedforward networks can learn arbitrary mappings.Neural Networks3 , 535–549 (1990).
- Sontag ED : Feedback stabilization using two-hidden-layers nets. IEEE Trans.Neural Networks3(6) , 981–990 (1992).
- Lin CT , LeeG: Neural Fuzzy Systems. Prentice-Hall, Upper Saddle River, NJ, USA (1996).
- Tomita Y , TomidaS, HasegawaY et al.: Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics5 , 120 (2004).
- Ritchie MD , WhiteBC, ParkerJS, Hahn LW, Moore JH: Optimization of neural network architecture using genetic programming improves detection and modeling of gene–gene interactions in studies of human diseases. BMC Bioinformatics4 , 28 (2003).
- Koza JR : Genetic Programming: on the programming of computers by means of natural selection. MIT Press, Cambridge, MA, USA (1992).
- North BV , CurtisD, CassellPG, Hitman GA, Sham PC: Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann. Hum. Genet.67348–67356 (2003).